Rivus Pharmaceuticals

Acquisition, funding and merger involving Rivus Pharmaceuticals.

• Rivus Pharmaceuticals has just announced a $132 Million fundraising (posted on September 27 2022).

View the org chart displaying its 9 main executives

Most searched biographies at Rivus Pharmaceuticals

• Jayson Dallas, Chief Executive Officer
• Derek DiRocco, Director
• Francesco De Rubertis, Director

Popular executive movements at Rivus Pharmaceuticals

• Ian Smith has joined the company as Chairman of the Board  (posted on November 16 2023).
• Robert Schott has joined the company as Chief Medical Officer  (posted on November 16 2023).

Create your alert
to follow the executive moves at Rivus Pharmaceuticals.

Rivus Pharmaceuticals has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Rivus Pharmaceuticals

• Rivus Pharmaceuticals

Social media about Rivus Pharmaceuticals

• Rivus Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Rivus Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Ian Smith

Call Rivus Pharmaceuticals at +1 703...

View the org chart

Register to receive your alert

Report an error